Scarica l'app Stockscreener
12.94
1.07%
-0.14
Dopo l'orario di chiusura:
12.94
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$13.08
Aprire:
$13.1
Volume 24 ore:
1.21M
Relative Volume:
0.44
Capitalizzazione di mercato:
$1.47B
Reddito:
-
Utile/perdita netta:
$-284.08M
Rapporto P/E:
-7.2697
EPS:
-1.78
Flusso di cassa netto:
$-234.65M
1 W Prestazione:
+7.12%
1M Prestazione:
+7.39%
6M Prestazione:
+80.47%
1 anno Prestazione:
+12.72%
Intervallo 1D:
$12.84
$13.23
Intervallo di 1 settimana:
$11.87
$13.50
Portata 52W:
$3.72
$13.50
Cogent Biosciences Inc Stock (COGT) Company Profile
Nome
Cogent Biosciences Inc
Settore
Industria
Telefono
617-945-5576
Indirizzo
275 WYMAN STREET, WALTHAM
Confronta COGT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
COGT
Cogent Biosciences Inc
|
12.94 | 1.68B | 0 | -284.08M | -234.65M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Cogent Biosciences Inc Stock (COGT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-07 | Iniziato | Scotiabank | Sector Outperform |
| 2024-12-11 | Downgrade | Needham | Buy → Hold |
| 2024-02-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-02-08 | Iniziato | Citigroup | Buy |
| 2023-12-11 | Downgrade | Wedbush | Outperform → Neutral |
| 2023-12-08 | Iniziato | JP Morgan | Overweight |
| 2023-04-28 | Iniziato | Robert W. Baird | Outperform |
| 2023-03-27 | Ripresa | H.C. Wainwright | Buy |
| 2022-12-14 | Iniziato | Needham | Buy |
| 2022-06-28 | Iniziato | Guggenheim | Buy |
| 2021-10-11 | Iniziato | H.C. Wainwright | Buy |
| 2021-06-09 | Ripresa | Jefferies | Buy |
| 2020-12-23 | Iniziato | Piper Sandler | Overweight |
| 2020-10-14 | Iniziato | Ladenburg Thalmann | Buy |
Mostra tutto
Cogent Biosciences Inc Borsa (COGT) Ultime notizie
Cogent Biosciences’ Strategic Position in the Evolving Biopharma Landscape - AInvest
Transcript : Cogent Biosciences, Inc. Presents at Citi's Biopharma Back to School Conference, Sep-03-2025 09 - MarketScreener
Is Cogent Biosciences Inc. stock risky to hold nowQuarterly Risk Review & Verified High Yield Trade Plans - khodrobank.com
Cogent Biosciences stock hits 52-week high at 13.01 USD - Investing.com
Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday - Benzinga
Is Cogent Biosciences Inc. forming a bullish divergenceGDP Growth & AI Enhanced Trade Execution Alerts - khodrobank.com
Raymond James Initiates Cogent Biosciences at Strong Buy - MarketScreener
Is Cogent Biosciences Inc. still worth holding after the dipPortfolio Return Summary & Expert-Curated Trade Recommendations - Newser
Will Cogent Biosciences Inc. rebound enough to break evenJuly 2025 Decliners & Smart Investment Allocation Insights - Newser
Cogent Biosciences Inc. stock daily chart insightsOil Prices & AI Optimized Trading Strategy Guides - Newser
What makes Cogent Biosciences Inc. stock price move sharplyJuly 2025 Trends & Risk Controlled Daily Trade Plans - Newser
Is it too late to sell Cogent Biosciences Inc.Long Setup & Accurate Buy Signal Alerts - Newser
Investment Report: Is Cogent Biosciences Inc. forming a bullish divergenceMarket Performance Summary & Stepwise Swing Trade Plans - khodrobank.com
Institutional scanner results for Cogent Biosciences Inc.Breakout Watch & Low Drawdown Momentum Ideas - Newser
How cyclical is Cogent Biosciences Inc.’s revenue streamQuarterly Earnings Report & Free Community Consensus Stock Picks - khodrobank.com
Developing predictive dashboards with Cogent Biosciences Inc. dataInflation Watch & Daily Oversold Bounce Ideas - Newser
What’s the recovery path for long term holders of Cogent Biosciences Inc.Earnings Recap Report & Capital Efficient Trade Techniques - Newser
Real time alert setup for Cogent Biosciences Inc. performanceJuly 2025 Update & AI Powered Market Entry Strategies - Newser
Can Cogent Biosciences Inc. ride the EV wave2025 Growth vs Value & Weekly High Conviction Ideas - khodrobank.com
Trend Reversal Possible in Cogent Biosciences Inc. Charts Indicate getLinesFromResByArray error: size == 0 - kangso.co.kr
Using AI based signals to follow Cogent Biosciences Inc.New Guidance & Low Risk Entry Point Tips - Newser
Should you hold or exit Cogent Biosciences Inc. nowWeekly Trade Review & Long-Term Capital Growth Ideas - Newser
Using data filters to optimize entry into Cogent Biosciences Inc.2025 Institutional Moves & Verified Entry Point Signals - Newser
Signal strength of Cogent Biosciences Inc. stock in tech scannersWeekly Trade Report & Community Consensus Picks - Newser
How sentiment analysis helps forecast Cogent Biosciences Inc.2025 Key Highlights & Technical Pattern Alert System - Newser
Automated trading signals detected on Cogent Biosciences Inc.2025 Institutional Moves & Growth Focused Stock Pick Reports - Newser
Cogent Biosciences Inc. Stock Flags Risk Zone in Volatility IndexEarnings Miss & Intraday High Probability Setup Alerts - beatles.ru
Technical analysis overview for Cogent Biosciences Inc. stockJuly 2025 Outlook & Real-Time Stock Price Movement Reports - Newser
Reversal Traders Monitor Cogent Biosciences Inc. for Entry getLinesFromResByArray error: size == 0 - 더경남뉴스
Reversal indicators forming on Cogent Biosciences Inc. stockJuly 2025 PostEarnings & AI Driven Stock Price Forecasts - Newser
How to use a screener to detect Cogent Biosciences Inc. breakoutsPortfolio Growth Summary & AI Driven Stock Reports - Newser
What to expect from Cogent Biosciences Inc. in the next 30 daysWeekly Investment Report & Fast Entry Momentum Alerts - Newser
Analyzing recovery setups for Cogent Biosciences Inc. investors2025 Investor Takeaways & Real-Time Sentiment Analysis - Newser
Using economic indicators to assess Cogent Biosciences Inc. potentialEarnings Risk Report & Long-Term Investment Growth Plans - Newser
Cogent Biosciences Inc Azioni (COGT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cogent Biosciences Inc Azioni (COGT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Pinnow Cole | Chief Commercial Officer |
Jan 14 '25 |
Buy |
7.60 |
43,750 |
332,412 |
45,848 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):